Success of Slovenian Medicine: First Gene Therapy for Rare Neurological Syndrome CTNNB1

Success of Slovenian Medicine: First Gene Therapy for Rare Neurological Syndrome CTNNB1
At the University Medical Centre (UKC) Ljubljana, a clinical study called GAIN-CTNNB1 began at the end of December, in which at least twelve children suffering from the neurological syndrome CTNNB1 wi...

Continue Reading

Get the full story in the Vaisti app

Download from App Store